Mercator Medical Statistics
Total Valuation
FRA:MM2 has a market cap or net worth of EUR 85.00 million. The enterprise value is 41.76 million.
| Market Cap | 85.00M |
| Enterprise Value | 41.76M |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 6.49M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.96% |
| Shares Change (QoQ) | +12.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 1.71% |
| Float | 3.79M |
Valuation Ratios
The trailing PE ratio is 3.71.
| PE Ratio | 3.71 |
| Forward PE | n/a |
| PS Ratio | 0.62 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.34, with an EV/FCF ratio of -1.78.
| EV / Earnings | 1.82 |
| EV / Sales | 0.30 |
| EV / EBITDA | 33.34 |
| EV / EBIT | n/a |
| EV / FCF | -1.78 |
Financial Position
The company has a current ratio of 6.95, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.95 |
| Quick Ratio | 3.73 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 4.43 |
| Debt / FCF | -0.24 |
| Interest Coverage | -38.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -1.86% |
| Revenue Per Employee | 144,453 |
| Profits Per Employee | 24,115 |
| Employee Count | 950 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -5.15M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.31% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -18.31% |
| 50-Day Moving Average | 9.43 |
| 200-Day Moving Average | 10.21 |
| Relative Strength Index (RSI) | 44.06 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:MM2 had revenue of EUR 137.23 million and earned 22.91 million in profits. Earnings per share was 2.47.
| Revenue | 137.23M |
| Gross Profit | 37.88M |
| Operating Income | -4.03M |
| Pretax Income | 17.80M |
| Net Income | 22.91M |
| EBITDA | 1.25M |
| EBIT | -4.03M |
| Earnings Per Share (EPS) | 2.47 |
Balance Sheet
The company has 47.69 million in cash and 5.53 million in debt, giving a net cash position of 42.16 million.
| Cash & Cash Equivalents | 47.69M |
| Total Debt | 5.53M |
| Net Cash | 42.16M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 208.59M |
| Book Value Per Share | 22.58 |
| Working Capital | 111.29M |
Cash Flow
In the last 12 months, operating cash flow was -13.97 million and capital expenditures -9.44 million, giving a free cash flow of -23.41 million.
| Operating Cash Flow | -13.97M |
| Capital Expenditures | -9.44M |
| Free Cash Flow | -23.41M |
| FCF Per Share | n/a |
Margins
Gross margin is 27.60%, with operating and profit margins of -2.94% and 16.69%.
| Gross Margin | 27.60% |
| Operating Margin | -2.94% |
| Pretax Margin | 12.97% |
| Profit Margin | 16.69% |
| EBITDA Margin | 0.91% |
| EBIT Margin | -2.94% |
| FCF Margin | n/a |
Dividends & Yields
FRA:MM2 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.96% |
| Shareholder Yield | 1.96% |
| Earnings Yield | 26.95% |
| FCF Yield | -27.55% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:MM2 has an Altman Z-Score of 4.82 and a Piotroski F-Score of 1.
| Altman Z-Score | 4.82 |
| Piotroski F-Score | 1 |